thiotepa has been researched along with Cancer of the Ureter in 4 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, DD | 1 |
| Boorjian, SA | 1 |
| Raman, JD | 1 |
| Powder, JR | 1 |
| Mosberg, WH | 1 |
| Pierpont, RZ | 1 |
| Tatoyan, KB | 1 |
| Young, JD | 1 |
| Seaman, EK | 1 |
| Slawin, KM | 1 |
| Benson, MC | 1 |
| Rutishauser, G | 1 |
| Klein, U | 1 |
1 review available for thiotepa and Cancer of the Ureter
| Article | Year |
|---|---|
Treatment options for upper tract transitional-cell carcinoma.
Topics: Administration, Topical; BCG Vaccine; Carcinoma, Transitional Cell; Combined Modality Therapy; Human | 1993 |
3 other studies available for thiotepa and Cancer of the Ureter
| Article | Year |
|---|---|
Intravesical chemotherapy use after radical nephroureterectomy: A national survey of urologic oncologists.
Topics: Administration, Intravesical; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Chem | 2017 |
Bilateral primary carcinoma of the ureter: topical intraureteral thiotepa.
Topics: Administration, Topical; Carcinoma, Transitional Cell; Humans; Male; Middle Aged; Neoplasm Recurrenc | 1984 |
[The so-called benign tumors of the urinary tract].
Topics: Adult; Female; Hematuria; Humans; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Papilloma; Thi | 1973 |